Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Andean & CAC | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
Ukraine | українська
United Kingdom | English
United States | English
    • About 
      • Novartis in India 
      • India Country Leadership Team 
      • Board of Directors of Novartis India Limited 
        • Christopher Snook 
        • Falin Ishwarlal Majmudar 
        • Gira Sardesai 
        • Sandra Martyres 
        • Sanker Parameswaran 
        • Shilpa Joshi 
      • Contact Us 
      Doctor with patient in the background
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      A couple holding hands
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Scientist in a lab
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      HCP with a patient on a walker
      ESG
    • Investors | Corporate Governance 
      • Shareholders' Information 
      • Annual General Meeting 
      • Corporate Policies 
      • Financials 
      • Stock Exchange Disclosures 
      • Transfer of Shares to IEPF Demat Account 
      • Novartis India Investors Contact 
      • Novartis India Annual General Meeting 
      • Novartis India Board of Directors 
      • Charter Documents 
      nkc-hyderabad
      Novartis India Investors | Corporate Governance
    • News 
      • News Archive 
      • Contacts 
      office-meeting
      News
    • Careers 
      • Career Search 
      • Diversity and Inclusion 
      • Our Business Functions 
      • People and Culture 
      • Why Novartis 
      A group of associates having fun at work
      Careers
    • Corporate Social Responsibility 
      • Environment 
      • Health 
    A happy moment with an HCP and an elderly patient
    Home

Quarterly Results

Financial Results - October 28, 2025

Financial Results - June 30, 2025

Financial Results - March 31, 2025

Financial Results - December 31, 2024

Financial Results – September 30, 2024 

Financial Results - June 30, 2024

Financial Results – March 31, 2024 

Financial Results – December 31, 2023

Financial Results - September 30, 2023

Financial Results - June 30, 2023

Financial Results - March 31, 2023

Financial Results - December 31, 2022

Financial Results - September 30, 2022

Financial Results - June 30, 2022

Financial Results - March 31, 2022

Financial Results - March 31, 2021

Financial Results - June 30, 2021

Financial Results - September 31, 2021

Financial Results - December 31, 2021

Financial Results - March 31, 2020 - (PDF 2.3 MB)

Financial Results - December 31, 2019 - (PDF 764 KB)

Financial Results - September 30, 2019 - (PDF 858 KB)

Financial Results - June 30, 2019 - (PDF 713 KB)

Financial Results - March 31, 2019 - (PDF 1 MB)

Financial Results - September 30, 2018 - (PDF 1 MB)

Financial Results - June 30, 2018 - (PDF 995 KB)

Financial Results - March 31, 2018 - (PDF 1.13 MB)

Financial Results - March 31, 2017 - (PDF 3.90 MB)

Financial Results - June 30, 2017 - (PDF 622 KB)

Financial Results - September 30, 2017 - (PDF 495 KB)

Financial Results - December 31, 2017 - (PDF 390 KB)

Financial Results – December 31,2016 - (PDF 3.45 MB)

Financial Results – September 30,2016 - (PDF 1.12 MB)

Financial Results – June 30, 2016 - (PDF 2.82 MB)

Financial Results – March 31, 2016 - (PDF 3,57 MB)

Financial Results – December 31, 2015 - (PDF 1,06 MB)

Financial Results - September 30, 2015 - (PDF 763 KB)

Financial Results - June 30, 2015 - (PDF 798 KB)

Financial Results - March 31, 2015 (PDF 246 KB)

Financial Results December 31, 2014 - (PDF 776 KB)

Financial Results September 30, 2014 - (PDF 771 KB)

Financial Results June 30, 2014 - (PDF 93,3 KB)

Financial Results March 31, 2014 - (PDF 459 KB)

Financial Results - December 31, 2013 - (PDF 106 KB)

Financial Results - September 31, 2013 - (PDF 655 KB)

Financial Results - June 30, 2013 - (PDF 88,6 KB)

Financial Results - March 31, 2013 - (PDF 108 KB)

Financial Results - December 31, 2012 - (PDF 97,2 KB)

Financial Results - September 30, 2012 - (PDF 791 KB)

Financial Results - June 30, 2012 - (PDF 489 KB)

Financial Results - March 31, 2012 - (PDF 442 KB)

Financial Results - December 31, 2011 - (PDF 94 KB)

Financial Results - September 31, 2011 - (PDF 466 KB)

Financial Results - June 30, 2011 - (PDF 55,6 KB)

Financial Results - March 31, 2011 - (PDF 147 KB)

Financial Results - December 31, 2010 - ( PDF 89,6 KB)

Financial Results - September 30, 2010 - (PDF 48,8 KB)

Financial Results - June 30, 2010 - (PDF 405 KB)

Financial Results - March 31, 2010 - (PDF 21,2 KB)

  • Print
  • PDF

Novartis India

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • Careers
  • Contacts
  • For Online resolution of disputes in the Indian Securities Market – please click SMART ODR Portal
Media Center
  • News
  • News Archive
  • Media Contacts
Our Portfolio
  • Novartis Clinical Pipeline
Other Novartis websites
  • Global site
  • Novartis MedHub India
Footer Bottom
© 2025 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in India